CONMED Corp — Director's Dealing 2020

Nov 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2020-11-16

Reporting Person: Berge Terence M (VP-Corporate Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-16	Common Stock	M	3600	$51.30	Acquired	23635	Direct
2020-11-16	Common Stock	F	2723	$98.21	Disposed	20912	Direct
2020-11-16	Common Stock	M	6400	$39.87	Acquired	27312	Direct
2020-11-16	Common Stock	S	6400	$96.289	Disposed	20912	Direct
2020-11-16	Common Stock	S	5000	$96.35	Disposed	15912	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-16	Sars (Stock Appreciation Rights)	$51.30	M	3600	Disposed	2025-02-27	Common Stock (3600)	Direct
2020-11-16	Options To Purchase Common Stock	$39.87	M	6400	Disposed	2026-03-01	Common Stock (6400)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.24 to $96.31. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period.

F3: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period